Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263) announced today it has entered into a research collaboration agreement with the Imperial College London, United-Kingdom, to develop next generation computer vision features for the use of optical biopsy based on the Cellvizio technology platform. The goal of this initiative will be to develop new imaging capabilities to improve the optical biopsy procedure and make it completely intuitive to clinicians of all specialties. This work will be done in coordination with Prof. Guang-Zhong Yang, Director of The Hamlyn Centre at Imperial College London.
Help employers find you! Check out all the jobs and post your resume.
